p16INK4a and p21Waf1/Cip1 expression correlates with clinical outcome in vulvar carcinomas
- 1 October 2004
- journal article
- research article
- Published by Elsevier in Gynecologic Oncology
- Vol. 95 (1), 37-45
- https://doi.org/10.1016/j.ygyno.2004.07.026
Abstract
No abstract availableKeywords
This publication has 50 references indexed in Scilit:
- Overexpression of p16INK4A as a specific marker for dysplastic and neoplastic epithelial cells of the cervix uteriInternational Journal of Cancer, 2001
- p16 alterations and retinoblastoma protein expression in squamous cell carcinoma and neighboring dysplasia from the upper aerodigestive tract.Virchows Archiv, 2001
- WAF1/p21 Protein Expression Is an Independent Prognostic Indicator in Superficial and Invasive Bladder CancerApplied Immunohistochemistry & Molecular Morphology, 2000
- Patterns of recurrence in patients with squamous cell carcinoma of the vulvaCancer, 2000
- CDK inhibitors: positive and negative regulators of G1-phase progressionGenes & Development, 1999
- Aberrant Expression of the Cell Cycle Associated Proteins TP53, MDM2, p21, p27, cdk4, Cyclin D1, RB, and EGFR in Cervical CarcinomasGynecologic Oncology, 1999
- The p21Cip1 and p27Kip1 CDK `inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblastsThe EMBO Journal, 1999
- The Prognostic Significance of Altered Cyclin-Dependent Kinase Inhibitors in Human CancerAnnual Review of Medicine, 1999
- Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancerNature Medicine, 1997
- Prognostic indicators for invasive carcinoma of the vulvaGynecologic Oncology, 1991